Literature DB >> 17051330

Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity.

Wei Wang1, Masaaki Adachi, Rina Kawamura, Hiroki Sakamoto, Toshiaki Hayashi, Tadao Ishida, Kohzoh Imai, Yasuhisa Shinomura.   

Abstract

The sesquiterpene lactone, parthenolide (PTL), possesses strong anticancer activity against various cancer cells. We report that PTL strongly induced apoptosis in 4 multiple myeloma (MM) cell lines and primary MM cells (CD38(+) high), but barely induced death in normal lymphocytes (CD38(-/+)low). PTL-mediated apoptosis correlated well with ROS generation and was almost completely inhibited by L-N-acetylcysteine (L-NAC), indicating the crucial role of oxidative stress in the mechanism. Among 4 MM cell lines, there is considerable difference in susceptibility to PTL. KMM-1 and MM1S cells sensitive to PTL possess less catalase activity than the less sensitive KMS-5 and NCI-H929 cells as well as normal lymphocytes. A catalase inhibitor 3-amino-1,2,4-triazole enhanced their PTL-mediated ROS generation and cell death. The siRNA-mediated knockdown of catalase in KMS-5 cells decreased its activity and sensitized them to PTL. Our findings indicate that PTL induced apoptosis in MM cells depends on increased ROS and intracellular catalase activity is a crucial determinant of their sensitivity to PTL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051330     DOI: 10.1007/s10495-006-0287-2

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  25 in total

1.  Independent component analysis: mining microarray data for fundamental human gene expression modules.

Authors:  Jesse M Engreitz; Bernie J Daigle; Jonathan J Marshall; Russ B Altman
Journal:  J Biomed Inform       Date:  2010-07-07       Impact factor: 6.317

2.  Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Authors:  Joshua N Kolev; Kristen M O'Dwyer; Craig T Jordan; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

3.  Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.

Authors:  M Czyz; K Lesiak-Mieczkowska; K Koprowska; A Szulawska-Mroczek; M Wozniak
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Authors:  Karin Jöhrer; Marlene Obkircher; Daniel Neureiter; Johanna Parteli; Claudia Zelle-Rieser; Eva Maizner; Johann Kern; Martin Hermann; Frank Hamacher; Olaf Merkel; Nathalie Wacht; Christian Zidorn; Marcel Scheideler; Richard Greil
Journal:  J Mol Med (Berl)       Date:  2011-12-29       Impact factor: 4.599

Review 5.  Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.

Authors:  Vivek Bhakta Mathema; Young-Sang Koh; Balkrishna Chand Thakuri; Mika Sillanpää
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.

Authors:  Yang Wang; Yudan Wei; Haiying Zhang; Yanfen Shi; Yulin Li; Ronggui Li
Journal:  Med Oncol       Date:  2011-02-10       Impact factor: 3.064

Review 7.  The role of oxidative stress in anticancer activity of sesquiterpene lactones.

Authors:  Katarzyna Gach; Angelika Długosz; Anna Janecka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-06       Impact factor: 3.000

8.  Evaluation of the DNA damaging effects of amitraz on human lymphocytes in the Comet assay.

Authors:  Milena Radakovic; Jevrosima Stevanovic; Ninoslav Djelic; Nada Lakic; Jelena Knezevic-Vukcevic; Branka Vukovic-Gacic; Zoran Stanimirovic
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

9.  Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells.

Authors:  Gauri Lamture; Peter A Crooks; Michael J Borrelli
Journal:  Drug Dev Res       Date:  2018-09-17       Impact factor: 4.360

10.  Preventing oxidative stress: a new role for XBP1.

Authors:  Y Liu; M Adachi; S Zhao; M Hareyama; A C Koong; Dan Luo; T A Rando; K Imai; Y Shinomura
Journal:  Cell Death Differ       Date:  2009-02-27       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.